Letter to Minister of Finance James M. Flaherty re: Demonstrating Canada’s Commitment to a Comprehensive Funding Plan for Universal Access to HIV Prevention, Care and Treatment by 2010

“At the Gleneagles Summit in July 2005, G8 leaders promised to develop and implement a package for HIV prevention, treatment and care, with the aim of as close as possible to universal access to treatment for all those who need it by 2010. Canada was among the countries that reaffirmed a commitment to this target … Read more

Canada’s 2003 renewed drug strategy — an evidence-based review — HIV/AIDS Policy & Law Review 11(2/3)

About three-quarters of the resources of Canada’s Drug Strategy are directed towards enforcement-related efforts, despite a lack of scientific evidence to support this approach and little, if any, evaluation of the impacts of this investment. In this feature article, the authors report on a study that examined expenditures and activities related to the Drug Strategy … Read more

HIV/AIDS Policy and Law Review 11(2/3) December 2006

FEATURES Canada’s 2003 renewed drug strategy — an evidence-based review Will they deliver treatment access?: WTO rules and Canada’s law on generic medicine exports The CDC’s routine HIV testing recommendation: legally, not so routine CANADIAN DEVELOPMENTS Supervised injection facility granted time-limited extension Federal prison guards call for power to test prisoners for HIV Sex workers: … Read more

The CDC’s routine HIV testing recommendation: legally, not so routine – HIV/AIDS Policy & Law Review 11(2/3)

In this feature article, Ann Hilton Fisher, Catherine Hanssens and David I. Schulman (from the ABA) analyze the new guidelines on HIV testing from the U.S. Centers for Disease Control and Prevention (CDC) and find them wanting. The authors argue that the CDC’s recommendation to do away with specific written informed consent for HIV tests … Read more